Boehringer Ingelheim plans to submit its app to treat under-addressed symptoms of schizophrenia for FDA clearance.

The ingestible capsule is about the size of a multivitamin, and once swallowed, it expands into a star shape that helps it remain in the stomach until all of the drug is released. CAMBRIDGE, MA -- For ...

Even under the best of circumstances, remembering to take a daily pill can be a challenge. For someone living with schizophrenia, it can be especially difficult. That’s because schizophrenia affects ...

The FDA on Thursday approved xanomeline and trospium chloride (Cobenfy) for schizophrenia in adults, the first new class of drug for the condition in more than 30 years. In contrast to antipsychotics ...

For the past 70 years, schizophrenia treatments all targeted the same chemical: dopamine. While that works for some, it causes brutal side effects for others. An antipsychotic drug approved last month ...

Common acne medications show surprising potential in lowering schizophrenia risk among vulnerable youth. Research suggests ...

Mapi is actively seeking additional partnerships for its new proprietary Depot products. Company management will be available for one-on-one meetings during the Annual Evercore Annual Healthcare ...